A patient with colorectal cancer is found to have a RAS mutation. What is the implication for treatment?
-
A
Eligible for cetuximab therapy
-
B
Not eligible for anti-EGFR therapy
-
C
Requires immediate surgical resection
-
D
Indicates sensitivity to bevacizumab